Staphylococcal Skin and Soft Tissue Infections

被引：60

作者：

Hatlen, Timothy J. ^{[1
,2
,3
,4
]}

Miller, Loren G. ^{[3
,4
,5
]}

机构：

[1] Harbor UCLA Med Ctr, Div Infect Dis, Torrance, CA 90509 USA

[2] Harbor UCLA Med Ctr, Div HIV, Torrance, CA 90509 USA

[3] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Torrance, CA 90509 USA

[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[5] Harbor UCLA Med Ctr, 1000 West Carson St,Box 466, Torrance, CA 90509 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2021年 / 35卷 / 01期

关键词：

Cellulitis with abscess; Purulent cellulitis; Suppurative cellulitis; Staphylococcus aureus skin infection; Acute bacterial skin and skin structure infections; ACUTE BACTERIAL SKIN; ONCE-WEEKLY DALBAVANCIN; COMPLICATED SKIN; TRIMETHOPRIM-SULFAMETHOXAZOLE; AUREUS INFECTIONS; DOUBLE-BLIND; FUSIDIC ACID; NECROTIZING FASCIITIS; CLINICAL-OUTCOMES; RESISTANT;

D O I：

10.1016/j.idc.2020.10.003

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Staphylococcus aureus is the most common bacteria causing purulent skin and soft tissue infections. Many disease-causing S aureus strains are methicillin resistant; thus, empiric therapy should be given to cover methicillin-resistant S aureus. Bacterial wound cultures are important for characterizing local susceptibility patterns. Definitive antibiotic therapy is warranted, although there are no compelling data demonstrating superiority of any one antibiotic over another. Antibiotic choice is predicated by the infection severity, local susceptibility patterns, and drug-related safety, tolerability, and cost. Response to therapy is expected within the first days; 5 to 7 days of therapy is typically adequate to achieve cure. © 2020 Elsevier Inc.

引用

页码：81 / 105

页数：25

共 106 条

[1] Does the Nose Know? An Update on MRSA Decolonization Strategies
Abad, C. L.
Pulia, M. S.
Safdar, N.
[J]. CURRENT INFECTIOUS DISEASE REPORTS, 2013, 15 (06) : 455 - 464
[2] Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis
Agarwal, R.
Bartsch, S. M.
Kelly, B. J.
Prewitt, M.
Liu, Y.
Chen, Y.
Umscheid, C. A.
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (04) : 361 - 368
[3] The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
Arbeit, RD
Maki, D
Tally, FP
Campanaro, E
Eisenstein, BI
[J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (12) : 1673 - 1681
[4] Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
Boucher, Helen W.
Wilcox, Mark
Talbot, George H.
Puttagunta, Sailaja
Das, Anita F.
Dunne, Michael W.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (23) : 2169 - 2179
[5] Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial
Bowen, Asha C.
Tong, Steven Y. C.
Andrews, Ross M.
O'Meara, Irene M.
McDonald, Malcolm I.
Chatfield, Mark D.
Currie, Bart J.
Carapetis, Jonathan R.
[J]. LANCET, 2014, 384 (9960) : 2132 - 2140
[6] Is Streptococcus pyogenes Resistant or Susceptible to Trimethoprim-Sulfamethoxazole?
Bowen, Asha C.
Lilliebridge, Rachael A.
Tong, Steven Y. C.
Baird, Robert W.
Ward, Peter
McDonald, Malcolm I.
Currie, Bart J.
Carapetis, Jonathan R.
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (12) : 4067 - 4072
[7] Adjunctive clindamycin for cellulitis: a clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis
Brindle, Richard
Williams, O. Martin
Davies, Paul
Harris, Tim
Jarman, Heather
Hay, Alastair D.
Featherstone, Peter
[J]. BMJ OPEN, 2017, 7 (03):
[8] Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008)
Castanheira, Mariana
Watters, Amy A.
Mendes, Rodrigo E.
Farrell, David J.
Jones, Ronald N.
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (07) : 1353 - 1358
[9] Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus
Cenizal, Mary Jo
Skiest, Daniel
Luber, Samuel
Bedimo, Roger
Davis, Pat
Fox, Patrick
Delaney, Kathleen
Hardy, R. Doug
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) : 2628 - 2630
[10] Chan Yi-Ling, 2002, Chang Gung Med J, V25, P437

← 1 2 3 4 5 6 7 8 9 10 →